NASDAQ:BRKR

Bruker Stock Forecast, Price & News

$80.79
-0.07 (-0.09 %)
(As of 07/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$80.50
$81.60
50-Day Range
$67.29
$82.35
52-Week Range
$37.27
$82.76
Volume416,862 shs
Average Volume580,527 shs
Market Capitalization$12.24 billion
P/E Ratio60.74
Dividend Yield0.20%
Beta1.29
30 days | 90 days | 365 days | Advanced Chart
Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.


Bruker logo

About Bruker

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.95 out of 5 stars

Computer And Technology Sector

304th out of 1,651 stocks

Analytical Instruments Industry

11th out of 36 stocks

Analyst Opinion: 1.1Community Rank: 3.2Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Bruker (NASDAQ:BRKR) Frequently Asked Questions

Is Bruker a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Bruker stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View analyst ratings for Bruker
or view top-rated stocks.

What stocks does MarketBeat like better than Bruker?

Wall Street analysts have given Bruker a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bruker wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Bruker?

Bruker saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 1,550,000 shares, an increase of 22.0% from the May 31st total of 1,270,000 shares. Based on an average trading volume of 625,800 shares, the short-interest ratio is currently 2.5 days. Approximately 1.5% of the shares of the stock are short sold.
View Bruker's Short Interest
.

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Monday, August 2nd 2021.
View our earnings forecast for Bruker
.

How can I listen to Bruker's earnings call?

Bruker will be holding an earnings conference call on Monday, August 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "10158977".

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) announced its quarterly earnings data on Tuesday, May, 4th. The medical research company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.32 by $0.12. The medical research company had revenue of $554.70 million for the quarter, compared to analyst estimates of $506.56 million. Bruker had a trailing twelve-month return on equity of 26.44% and a net margin of 9.63%. The company's quarterly revenue was up 30.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.14 EPS.
View Bruker's earnings history
.

How has Bruker's stock price been impacted by COVID-19?

Bruker's stock was trading at $40.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BRKR stock has increased by 102.0% and is now trading at $80.79.
View which stocks have been most impacted by COVID-19
.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Thursday, May 13th. Investors of record on Tuesday, June 1st will be paid a dividend of $0.04 per share on Friday, June 18th. This represents a $0.16 dividend on an annualized basis and a yield of 0.20%. The ex-dividend date of this dividend is Friday, May 28th.
View Bruker's dividend history
.

Is Bruker a good dividend stock?

Bruker pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.20%. Bruker does not yet have a strong track record of dividend growth. The dividend payout ratio of Bruker is 11.85%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Bruker will have a dividend payout ratio of 7.41% next year. This indicates that Bruker will be able to sustain or increase its dividend.
View Bruker's dividend history.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY 2021 earnings guidance on Thursday, July, 15th. The company provided earnings per share guidance of $1.840-$1.890 for the period, compared to the Thomson Reuters consensus estimate of $1.870. The company issued revenue guidance of $2.31 billion-$2.35 billion, compared to the consensus revenue estimate of $2.32 billion.

What price target have analysts set for BRKR?

7 brokerages have issued twelve-month price objectives for Bruker's shares. Their forecasts range from $50.00 to $85.00. On average, they anticipate Bruker's stock price to reach $66.50 in the next year. This suggests that the stock has a possible downside of 17.7%.
View analysts' price targets for Bruker
or view top-rated stocks among Wall Street analysts.

Who are Bruker's key executives?

Bruker's management team includes the following people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 61, Pay $1.15M)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 63, Pay $603.02k)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 59, Pay $772.26k)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 66, Pay $636.53k)
  • Dr. Falko Busse Ph.D., Pres of Bruker BioSpin Group (Age 54, Pay $571.75k)
  • Ms. Miroslava Atanassova Minkova, Director of Investor Relations & Corp. Devel.
  • Mr. Collin J. D'Silva, Pres of Chemical Analysis Division (Age 64)
  • Stacey Desrochers, Treasurer & Director of Investor Relations
  • Mr. Urban Faeh, Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH
  • Dr. Burkhard Prause, Pres and CEO of Bruker Energy & Supercon Technologies, Inc. (Age 54)

What is Frank H. Laukien's approval rating as Bruker's CEO?

75 employees have rated Bruker CEO Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among Bruker's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), The Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by a number of retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.01%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Marc A Kastner and Mark Munch.
View institutional ownership trends for Bruker
.

Which major investors are buying Bruker stock?

BRKR stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue.
View insider buying and selling activity for Bruker
or or view top insider-buying stocks.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $80.79.

How much money does Bruker make?

Bruker has a market capitalization of $12.24 billion and generates $1.99 billion in revenue each year. The medical research company earns $157.80 million in net income (profit) each year or $1.35 on an earnings per share basis.

How many employees does Bruker have?

Bruker employs 7,400 workers across the globe.

Does Bruker have any subsidiaries?

The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK In­stru­ments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.

When was Bruker founded?

Bruker was founded in 1960.

What is Bruker's official website?

The official website for Bruker is www.bruker.com.

Where are Bruker's headquarters?

Bruker is headquartered at 40 Manning Road, Billerica MA, 01821.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at (978) 663-3660 or via email at [email protected]


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.